FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
HYPAQUE
diatrizoate sodium
LOE Approaching
INJECTION · INJECTABLE
1954
NDA30/100
HYPAQUE
diatrizoate meglumine
LOE Approaching
INJECTION · INJECTABLE
1969
NDA30/100
HYPAQUE
diatrizoate sodium
LOE Approaching
ORAL, RECTAL · SOLUTION
1956
NDA30/100
HYPAQUE SODIUM 20%
diatrizoate sodium
LOE Approaching
URETERAL · SOLUTION
1954
NDA30/100
HYPAQUE-CYSTO
diatrizoate meglumine
LOE Approaching
URETHRAL · SOLUTION
1969
NDA30/100
HYPAQUE-M,75%
diatrizoate meglumine; diatrizoate sodium
LOE Approaching
INJECTION · INJECTABLE
1955
NDA30/100
HYPAQUE-M,90%
diatrizoate meglumine; diatrizoate sodium
LOE Approaching
INJECTION · INJECTABLE
1955
NDA30/100
HYPERSTAT
diazoxide
LOE Approaching
Merck & Co.
INJECTION · INJECTABLE
1973
NDA30/100
HYPROTIGEN 5%
protein hydrolysate
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1947
NDA30/100
HYTRIN
terazosin hydrochloride
LOE Approaching
Abbott
ORAL · CAPSULE
1994
NDA30/100
HYTRIN
terazosin hydrochloride
LOE Approaching
Abbott
ORAL · TABLET
1987
NDA30/100
HYZAAR
losartan potassium and hydrochlorothiazide
LOE Approaching
Merck & Co.
ORAL · TABLET
hypertensionto lower blood pressure+3
1995
NDA30/100
IBU
ibuprofen
LOE Approaching
ORAL · TABLET
1981
SMNDA30/100
IBU
ibuprofen
LOE Approaching
Abbott
ORAL · SUSPENSION
1989
SMNDA30/100
IC-GREEN
indocyanine green
LOE Approaching
INJECTION · INJECTABLE
1959
NDA30/100
IDAMYCIN
idarubicin hydrochloride
LOE Approaching
Pfizer
INTRAVENOUS · POWDER
1990
NDA30/100
IDAMYCIN PFS
idarubicin hydrochloride
LOE Approaching
Pfizer
INTRAVENOUS · SOLUTION
1997
NDA30/100
IDARUBICIN HYDROCHLORIDE
idarubicin hydrochloride
LOE Approaching
Pfizer
INTRAVENOUS · SOLUTION
1997
NDA30/100
IDKIT:HP
citric acid anhydrous and 13c urea
LOE Approaching
CooperSurgical
ORAL · FOR SOLUTION, TABLET, FOR SOLUTION
2002
NDA30/100
IFEX
ifosfamide
LOE Approaching
Baxter
INJECTION · INJECTABLE
1987
NDA30/100
IFEX/MESNEX KIT
ifosfamide
LOE Approaching
Baxter
INJECTION · INJECTABLE
1987
NDA30/100
ILOSONE
erythromycin estolate
LOE Approaching
Eli Lilly and Company
ORAL · SUSPENSION
1967
NDA30/100
ILOTYCIN
erythromycin
LOE Approaching
OPHTHALMIC · OINTMENT
1964
NDA30/100
IMAGENT
dimyristoyl lecithin; perflexane
LOE Approaching
INTRAVENOUS · INJECTABLE
2002
NDA30/100